GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (OTCPK:ARSUF) » Definitions » Purchase Of Business

ARSUF (Fagron) Purchase Of Business : $-31.0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Fagron Purchase Of Business?

Fagron's purchase of business for the six months ended in Dec. 2024 was $-6.2 Mil. It means Fagron spent $6.2 Mil on purchasing business. Fagron's purchase of business for the trailing twelve months (TTM) ended in Dec. 2024 was $-31.0 Mil.

Compared with last quarter ($-24.8 Mil in Jun. 2024 ), Fagron spent less money on purchasing business in Dec. 2024 ($-6.2 Mil).


Fagron Purchase Of Business Historical Data

The historical data trend for Fagron's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron Purchase Of Business Chart

Fagron Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only -40.00 -12.65 -57.20 -6.85 -30.31

Fagron Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.80 -6.00 -0.81 -24.78 -6.21

Fagron Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-31.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fagron Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Fagron's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Fagron Business Description

Traded in Other Exchanges
Address
Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.

Fagron Headlines

From GuruFocus

Q3 2021 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Q2 2024 Fagron NV Earnings Call Transcript

By GuruFocus News 10-09-2024

Fagron NV At Capital Markets Day Transcript

By GuruFocus Research 02-12-2024

Q1 2019 Fagron NV Corporate Sales Call Transcript

By GuruFocus Research 02-12-2024

Q1 2022 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Full Year 2019 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q4 2021 Fagron NV Earnings Presentation Transcript

By GuruFocus Research 02-12-2024

Q4 2020 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2022 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024